Citadel Advisors’s GE HealthCare GEHC Stock Holding History
Bought
Maintained
Sold
Other funds holding GEHC
Citadel Advisors's GEHC Position: Q2 2026 in Review
Citadel Advisors increased its GE HealthCare (GEHC) stake by 83% in Q2 2026, buying an estimated $70.6M and bringing the position to 2,367,032 shares worth $152M. The position accounts for 0.02% of the portfolio, ranked #707.
Citadel Advisors first reported a position in GEHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $689M in Q2 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.
- Citadel Advisors held 2,367,032 shares of GE HealthCare worth $152M as of Q2 2026.
- Citadel Advisors bought 1,073,764 GE HealthCare shares in Q2 2026, an estimated $70.6M.
- GE HealthCare made up 0.02% of Citadel Advisors's portfolio in Q2 2026, its #707 holding.
- Citadel Advisors first reported a position in GE HealthCare in Q4 2022 and has held it in 15 quarters since.
- Citadel Advisors's GE HealthCare position peaked at $689M in Q2 2025.
- 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.